Genomic Sequencing Surveillance Improves Detection of Healthcare-Associated Transmission of Vancomycin-Resistant Enterococci

Researchers from the University of Pittsburgh have conducted a study on the transmission dynamics of vancomycin-resistant enterococcal (VRE) infections, highlighting the importance of using whole genome sequencing (WGS) surveillance of both clinical and rectal screening isolates to better understand the transmission of this pathogen. The study found that VRE rectal carriage constituted 87.3% of VRE acquisition, with an average monthly acquisition rate of 7.6 per 1000 patient days. The inclusion of rectal swab isolates increased the detection of clinical isolate clusters, demonstrating the potential utility of incorporating WGS surveillance of VRE into routine hospital practice for improving infection prevention and patient safety.

Key Takeaways:

  • The study found that VRE rectal carriage was the primary mode of VRE acquisition, with 87.3% of cases resulting from rectal carriage.
  • The average monthly acquisition rate of VRE was 7.6 per 1000 patient days.
  • The inclusion of rectal swab isolates increased the detection of clinical isolate clusters from 53 to 67%, highlighting the importance of incorporating WGS surveillance into routine hospital practice.
  • The study identified 185 genetically related clusters containing 2-42 isolates and encompassing 70% of all isolates in the dataset.
  • The research suggests that WGS surveillance of both clinical and rectal screening isolates is crucial for understanding the transmission dynamics of VRE.
  • The study's findings have significant implications for improving infection prevention and patient safety in hospitals.

Statistics:

  • 87.3% of VRE acquisitions resulted from rectal carriage.
  • The average monthly acquisition rate of VRE was 7.6 per 1000 patient days.
  • 53% of clinical isolate clusters were detected upon inclusion of rectal swab isolates.
  • 67% of clinical isolate clusters were detected when rectal swab isolates were included, compared to 53% when only clinical isolates were considered.

Sources:

  • Genomic sequencing surveillance of patients colonized with vancomycin-resistant enterococci improves detection of healthcare-associated transmission. BMC Global and Public Health, 2025, 3(1):1-11.
  • NewsRx. Recent Studies from University of Pittsburgh Add New Data to Antibiotics (Genomic sequencing surveillance of patients colonized with vancomycin-resistant enterococci improves detection of healthcare-associated transmission). Life Science Weekly. September 2, 2025; p 3978.